Helius Medical Technologies, Inc. provided revenue guidance for the third quarter for 2022. For the quarter, the company expects revenue to be modestly above the second quarter levels, factoring in the timing required to pair patients with trained physical therapists and potential delays for some portion of U.S. patients to pursue insurance coverage prior to filling their prescriptions.
Helius Medical Technologies, Inc.
Equities
HSDT
US42328V8019
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.24 USD | -3.12% | -16.22% | -84.58% |
13/05 | Transcript : Helius Medical Technologies, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
13/05 | Earnings Flash (HSDT) HELIUS MEDICAL TECHNOLOGIES Posts Q1 Revenue $135,000 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-84.58% | 46.38L | |
+10.03% | 22TCr | |
+13.59% | 19TCr | |
+20.01% | 14TCr | |
+30.83% | 11TCr | |
+2.05% | 6.5TCr | |
+15.38% | 5.3TCr | |
+3.96% | 5.04TCr | |
+8.37% | 4.42TCr | |
+3.27% | 3.64TCr |
- Stock Market
- Equities
- HSDT Stock
- News Helius Medical Technologies, Inc.
- Helius Medical Technologies, Inc. Provides Revenue Guidance for the Third Quarter for 2022